Holen Sie sich die Stockscreener-App
150.80
2.46%
3.69
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Illumina launches cloud-based platform for multiomic data analysis - Investing.com
Illumina launches cloud-based platform for multiomic data analysis By Investing.com - Investing.com India
Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis - PR Newswire
DNA Test Kits Market Booming with Rapid Growth Through 2033 |Devyser, Illumina, Inc., Living DNA Ltd - openPR.com
Why Illumina (ILMN) Is Up 6.5% After Advancing Grail Divestiture Plan And What's Next - Yahoo Finance UK
Next Generation Sequencing (NGS) Market to Reach US$ 35.92 - openPR.com
Illumina’s Crossroads: Genomics Pioneer Tests Investor Patience As Wall Street Reassesses The Stor - AD HOC NEWS
Generali Asset Management SPA SGR Has $2.11 Million Stock Position in Illumina, Inc. $ILMN - MarketBeat
Forecast Cut: Is Illumina Inc stock a smart buy before Fed meetingTrade Exit Summary & AI Based Trade Execution Alerts - moha.gov.vn
Illumina (NASDAQ:ILMN) Lowered to "Hold" Rating by Zacks Research - MarketBeat
Illumina Inc.: Can the Genomics Pioneer Reinvent Itself for the AI Era? - AD HOC NEWS
Illumina (NASDAQ:ILMN) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Aug Macro: Is Illumina Inc stock dividend yield sustainable2025 Valuation Update & Entry Point Confirmation Signals - moha.gov.vn
Who Owns Illumina? Top Shareholders and Recent Insider Trades - TIKR.com
Biomarker Discovery Market to Reach US$ 54.19 Billion by 2033 - openPR.com
273,111 Shares in Illumina, Inc. $ILMN Purchased by VIRGINIA RETIREMENT SYSTEMS ET Al - MarketBeat
Earnings Are Growing at Illumina (NASDAQ:ILMN) but Shareholders Still Don't Like Its Prospects - 富途牛牛
Illumina stock at a crossroads: genomics giant tests investor patience as Wall Street recalibrates e - AD HOC NEWS
Here's Why Illumina (ILMN) is a Strong Momentum Stock - Yahoo Finance
Japan Nucleic Acid Isolation and Purification Market is Driven - openPR.com
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Reproductive Genetics Market Size to Reach USD 16.67 Billion in 2032 Amid Increasing Demand for Genetic Testing - GlobeNewswire Inc.
Illumina, Inc. $ILMN Shares Bought by Cwm LLC - MarketBeat
Pacer Advisors Inc. Acquires New Position in Illumina, Inc. $ILMN - MarketBeat
Voya Investment Management LLC Has $5.23 Million Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
United states DNA Forensics Market to Reach USD 5.60 Billion - openPR.com
Take Profit: Is Illumina Inc. stock undervalued vs historical averagesJuly 2025 Short Interest & AI Driven Price Predictions - moha.gov.vn
Swedbank AB Grows Position in Illumina, Inc. $ILMN - MarketBeat
Life Science Instruments & Consumables Market to Reach USD - openPR.com
Genomics in Cancer Care Market to Reach USD 72.87 Billion by 2033 | - openPR.com
Illumina Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Genomics Market Outlook: Market to Reach US$ 118.2 Billion - openPR.com
Illumina Inc ILU Stock Analysis and ForecastTechnical Breakout Signals & Fast Growing Capital Growth - earlytimes.in
Is Illumina Inc Gaining or Losing Market Support? - Sahm
Illumina, Inc. $ILMN Stock Holdings Lessened by Assenagon Asset Management S.A. - MarketBeat
Canaccord Genuity Maintains Illumina (ILMN) Hold Recommendation - Nasdaq
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina (NASDAQ:ILMN) Price Target Raised to $130.00 - MarketBeat
Illumina (ILMN) Surges 3.3%: Is This an Indication of Further Gains? - Nasdaq
Illumina Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
Douglas Lane & Associates LLC Acquires 18,914 Shares of Illumina, Inc. $ILMN - MarketBeat
Why Illumina Inc. (ILU) stock could rally stronglySwing Trade & Stepwise Trade Signal Guides - Улправда
Illumina (ILMN): Evaluating the Stock’s Valuation After Its Strategic AI-Genomics Partnership With MyOme - Yahoo Finance
Why hedge funds are buying Illumina Inc. stockJuly 2025 Rallies & Risk Controlled Stock Alerts - Улправда
Can Illumina Inc. stock deliver consistent earnings growthJuly 2025 Sector Moves & Weekly Chart Analysis and Guides - Улправда
Is Illumina Inc. stock a smart buy before Fed meetingJuly 2025 Retail & Fast Gain Stock Trading Tips - DonanımHaber
Why Illumina Inc. (ILU) stock stays on buy listsStop Loss & AI Powered Buy and Sell Recommendations - DonanımHaber
Is Illumina Inc. stock undervalued vs historical averages2025 Year in Review & Smart Money Movement Alerts - ulpravda.ru
Will Illumina Inc. stock outperform international peersWeekly Investment Report & Expert Verified Movement Alerts - ulpravda.ru
Is Illumina Inc. stock supported by innovation pipelineWeekly Trading Summary & Real-Time Price Movement Reports - Улправда
“It can’t wait until tomorrow”: How patient advocacy drives change - Illumina
DNA/Gene Microarray Market Growth Potential Examined Through - openPR.com
Illumina, Inc. $ILMN Shares Acquired by Aaron Wealth Advisors LLC - MarketBeat
Illumina Inc (NASDAQ:ILMN) Nasdaq Futures Shape Discovery Market Now - Kalkine Media
Discipline and Rules-Based Execution in ILMN Response - news.stocktradersdaily.com
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Illumina Target of Unusually Large Options Trading (NASDAQ:ILMN) - MarketBeat
How AstraZeneca improved their genomics processing to be 60% faster, 70% more cost-effective - Amazon Web Services (AWS)
Sicart Associates LLC Has $7.89 Million Stock Position in Illumina, Inc. $ILMN - MarketBeat
Scott Davies Sells 323 Shares of Illumina (NASDAQ:ILMN) Stock - MarketBeat
0.09%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):